✦ LIBER ✦

Post marketing survey on the safety of sublingual immunotherapy in children below the age of 5

✍ Scribed by Passalacqua, G.; Di Rienzo, V.; Minelli, M.; Musarra, A.; Sambugaro, R.; Pecora, S.; Canonica, G.W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Post-marketing survey on the safety of s

✍ V. Di Rienzo; M. Minelli; A. Musarra; R. Sambugaro; S. Pecora; W. G. Canonica; G 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

A prospective study on safety of subling

✍ Fiocchi, A.; Paino, G.; La Grutta, S.; Pezzuto, F.; Incorvaia, C.; Sensi, L.; Ma 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 28 KB

The safety of sublingual immunotherapy w

✍ F. Agostinis; C. Foglia; M. Landi; M. Cottini; C. Lombardi; G. W. Canonica; G. P 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

A prospective study on the safety of sub

✍ W. A. Shaikh; S. W. Shaikh 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

ALLERGY Net: The safety of sublingual im

✍ C. Lombardi; S. Gargioni; M. Cottini; G. W. Canonica; G. Passalacqua 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Safety and efficacy of etanercept in chi

✍ N. Tzaribachev; J. Kuemmerle-Deschner; M. Eichner; G. Horneff 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 209 KB